Publications & Reports

Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.

Wilkinson BL, Day S, Malins LR, Apostolopoulos V, Payne RJ
School of Chemistry, The University of Sydney, New South Wales 2006, Australia.

Publication

  • Journal: Angewandte Chemie
  • Published: 11/02/2011
  • Volume: 50
  • Issue: 7
  • Pagination: 1635-1639